Alixia
Targeting the Tumor Ecosystem to address cancer drug resistance.
San Francisco, United States · Founded 2022 · $2.1M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2022
- Website
- alixia.com
- Total Funding
- $2.1M
- Last Round
- $1.8M Series AJul 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.
Summary
Alixia is a Biotech company based in San Francisco, United States, founded in 2022. It has raised $2.1M in total across 2 rounds, most recently a $1.8M Series A round in Jul 2024. Investors include ZAKA VC, Y Combinator and Endless Frontier Labs.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2024
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alixia-therapeutics"><img src="https://indexed.vc/api/badge/company/alixia-therapeutics" alt="Alixia on Indexed.vc" width="260" height="76" /></a>